article thumbnail

The next revolution in the pharmaceutical industry: the transformative potential of AI

Digital Health Global

The pharmaceutical landscape is undergoing a momentous transformation, marked by the convergence of cutting-edge technologies that are redefining every aspect of the industry. The first application of AI to the pharmaceutical industry is its use in ramping up and improving new drug discovery.

article thumbnail

Could digital therapeutics be the next frontier in mental health?

DigitalHealth

With the ever-increasing prominence of digital technologies in healthcare, digital therapeutics (DTx) present a novel treatment avenue across disease areas, which could support and improve existing care strategies.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Committee to Restore Nymox Shareholder Value Sends Letter to Nymox Pharmaceutical Shareholders and Issues Proxy Materials for Upcoming Special Meeting

Digital Health Global

CRNSV”) was formed by former executives and directors of Nymox Pharmaceutical Corporation (“Nymox” or the “Company”), who were improperly removed from their positions, with a goal to recover shareholder value in Nymox. & LONDON–(BUSINESS WIRE)– The Committee to Restore Nymox Shareholder Value, Inc.

article thumbnail

Orion Corporation and Newel Health enter into licensing agreement for a digital therapeutic (DTx) ODD-403 (“Rohkea”) in pain

Digital Health Global

Today we are excited to welcome ODD-403 under our wing for further development and introduction to market, adding Virtual Reality modalities to our growing portfolio of partner-ready DTx solutions,” says Gerry Chillè , Chief Strategy Officer at Newel Health. The core therapy areas of our pharmaceutical R&D are oncology and pain.

article thumbnail

Akili Announces Amended Agreement with Shionogi, Shift in Corporate Strategy and Release Date for First Quarter 2024 Financial Results

Digital Health Global

Shionogi”), a leading global pharmaceutical company. (Nasdaq: AKLI), a leading digital medicine company, today provided several corporate updates, including an amendment to its strategic distribution agreement with Shionogi & Co., Under the terms of the amended agreement, Shionogi has canceled and forgiven a $5.0

article thumbnail

Crossing the Chasm for Digital Therapeutics (DTx) in Pharmaceuticals

care innovations

Pharmaceuticals are no longer looking for a point-based product, but rather a group of services that engage patients in a way that increases adoption and adherence for medical purposes. We’re seeing a shift in how care, technology, and adherence are coming together as a blended solution in the healthcare industry. About the author.

article thumbnail

EVERSANA Completes Integration of Healthware Group and Strengthens Its Global Agency Network EVERSANA INTOUCH With Addition of New Full-Service Affiliate

Digital Health Global

EVERSANA INTOUCH Healthware joins five full-service affiliates and four specialty affiliates serving clients across the globe with world-class strategy, next-generation branding and creative, and innovative solutions to propel the future of life science marketing. They are, however, fully owned and operated by EVERSANA.